Skip to main content

CORRECTION article

Front. Mol. Biosci.

Sec. Molecular Diagnostics and Therapeutics

Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1599157

This article is part of the Research Topic Cancer Biomarkers: Molecular Insights into Diagnosis, Prognosis, and Risk Prediction View all 14 articles

"Corrigendum:"CircMlB1 inhibits glioma development and progression through a competing endogenous RNA interaction network"

Provisionally accepted
Simin Chen Simin Chen 1Longping Li Longping Li 1Wei Xu Wei Xu 1Nanjiao Xie Nanjiao Xie 1Huiting Xu Huiting Xu 1Yongjun Zhou Yongjun Zhou 1Ying Zou Ying Zou 1Kai Yi Kai Yi 1Zuping Zhang Zuping Zhang 2*
  • 1 Yiyang Central Hospital, Yiyang, China
  • 2 Central South University, Changsha, Hunan Province, China

The final, formatted version of the article will be published soon.

    Incorrect AffiliationIn the published article, there was an error in affiliation(s) 2. Instead of “Department of Emergency Medicine and Laboratory of Emergency Medicine, West China Hospital, West China School of Medicine, Sichuan University Chengdu, Chengdu, 610041 People’s Republic of China.”, it should be “School of Xiangya Basic Medical Science, Central South University, Changsha 410013, Hunan, China.”The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.Error in Author List1.In the published article, there was an error in the author list, and author Zuping Zhang was erroneously excluded. The corrected author list appears below.2.In the published article, there was an error in the author list, and author Yi Liu was erroneously included. The corrected author list appears below.Simin Chen1†, Longping Li1†, Wei Xu1, Nanjiao Xie1, Huiting Xu1, Yongjun Zhou1, Ying Zou1, Kai Yi1, Zuping Zhang2*The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.Incorrect Funding In the published article, there was an error in the Funding statement. Due to an oversight on the part of the first author, the full name of Funding does not correspond to the official. The correct Funding statement appears below.FUNDINGOur research was supported by Hunan Provincial Natural Science Foundation of China (No. 2024JJ9575).The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

    Keywords: CircMIB1, Glioma, MiR-1290, ceRNA, prognostic, biomarker

    Received: 31 Mar 2025; Accepted: 31 Mar 2025.

    Copyright: © 2025 Chen, Li, Xu, Xie, Xu, Zhou, Zou, Yi and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zuping Zhang, Central South University, Changsha, 130012, Hunan Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more